Opinion|Videos|August 28, 2024
Treatment Options for Central Precocious Puberty
Key opinion leaders analyze current treatment guidelines for Central Precocious Puberty while offering insights on navigating treatment selection in scenarios lacking established protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Can you review current guidelines for treatment of CPP?
- What are the therapies currently available for CPP?
- Can you provide insights on how you navigate treatment selection and approach without available guidelines?
Advertisement
Related to this article
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
Advertisement
Advertisement